AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 2 filers reported holding AXSOME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,175 | +23400.0% | 16,810 | +22927.4% | 0.00% | – |
Q2 2023 | $5 | -100.0% | 73 | -99.7% | 0.00% | -100.0% |
Q3 2022 | $1,186,000 | -40.4% | 26,572 | -56.0% | 0.00% | 0.0% |
Q3 2021 | $1,990,000 | -71.6% | 60,371 | -41.8% | 0.00% | -75.0% |
Q2 2021 | $6,997,000 | +252.7% | 103,717 | +196.0% | 0.00% | +300.0% |
Q1 2021 | $1,984,000 | +113.1% | 35,036 | +206.5% | 0.00% | – |
Q4 2020 | $931,000 | +14.2% | 11,432 | 0.0% | 0.00% | – |
Q3 2020 | $815,000 | -44.3% | 11,432 | -35.8% | 0.00% | -100.0% |
Q2 2020 | $1,464,000 | -89.7% | 17,793 | -92.6% | 0.00% | -90.9% |
Q1 2020 | $14,175,000 | -14.5% | 240,971 | +50.3% | 0.01% | +10.0% |
Q4 2019 | $16,573,000 | +2639.3% | 160,338 | +436.2% | 0.01% | – |
Q3 2019 | $605,000 | -78.2% | 29,900 | -72.3% | 0.00% | -100.0% |
Q2 2019 | $2,778,000 | +6.7% | 107,860 | -41.1% | 0.00% | 0.0% |
Q1 2019 | $2,604,000 | +8580.0% | 182,975 | +1642.6% | 0.00% | – |
Q4 2018 | $30,000 | -74.4% | 10,500 | -71.2% | 0.00% | – |
Q2 2018 | $117,000 | +34.5% | 36,500 | +2.5% | 0.00% | – |
Q1 2018 | $87,000 | -10.3% | 35,600 | +103.4% | 0.00% | – |
Q3 2017 | $97,000 | +9.0% | 17,500 | +8.1% | 0.00% | – |
Q2 2017 | $89,000 | +196.7% | 16,190 | +106.1% | 0.00% | – |
Q1 2017 | $30,000 | +2900.0% | 7,857 | +5552.5% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 139 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | – | 139 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |